Juvenile rheumatoid arthritis (JRA) is characterized by several subtypes, whereas RA is more homogeneous. There are differences in outcome: adults with RA tend to have a poorer outcome; in JRA, the outcome is more variable and can be predicted by phenotypes at presentation.
ICD-10 code M08 Juvenile arthritis can be used to indicate a diagnosis of the condition for reimbursement purposes. Relevant codes under ICD-10 code M08 include: M08. 0 Unspecified juvenile rheumatoid arthritis.
JIA used to be called juvenile rheumatoid arthritis (JRA), but the name changed because it is not a kid version of the adult disease. The term “juvenile arthritis” is used to describe all the joint conditions that affects kids and teens, including JIA.
Juvenile idiopathic arthritis, formerly known as juvenile rheumatoid arthritis, is the most common type of arthritis in children under the age of 16. Juvenile idiopathic arthritis can cause persistent joint pain, swelling and stiffness.
M06. 9 - Rheumatoid arthritis, unspecified | ICD-10-CM.
Juvenile rheumatoid arthritis (JRA), often referred to by doctors today as juvenile idiopathic arthritis (JIA), is a type of arthritis that causes joint inflammation and stiffness for more than six weeks in a child aged 16 or younger. It affects approximately 50,000 children in the United States.
Because JIA was previously known as juvenile rheumatoid arthritis (JRA), many people assume JIA is simply a child version of adult rheumatoid arthritis (RA). Though JIA and adult RA are both forms of inflammatory arthritis, these conditions are distinct.
It involves both small and large joints, most commonly knees, wrists, ankles, elbows and proximal interphalangeal joints (PIP) joints. Fusion of the wrists is a characteristic late finding. Adults with JRA present with severe and debilitating myalgias, which coincide with fever spikes.
The three major types include: Oligoarticular JIA (arthritis in four joints or less) Polyarticular JIA (arthritis in five or more joints) Systemic JIA (arthritis plus fever, rash and large lymph nodes)
Treatment for juvenile rheumatoid arthritis is aimed at stopping inflammation to preserve normal function of the joints and other organ systems. Treatments may include: Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen (Aleve), to reduce pain and swelling.
Disease-modifying anti-rheumatic drugs (DMARDs) are often used if NSAIDs don't provide enough relief. DMARDs may keep JRA from getting worse. But because they take weeks or months to relieve symptoms, they're often taken with an NSAID. Methotrexate is usually the main DMARD doctors prescribe for JRA.
Juvenile arthritis is an autoimmune disease. That means the immune system, which normally protects the body from foreign substances, attacks the body instead. The disease is also idiopathic, which means that no exact cause is known.